Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

Active, not recruitingOBSERVATIONAL
Enrollment

6,134,060

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

September 30, 2026

Conditions
Pancreatic AdenocarcinomaPredictive Cancer Model
Interventions
OTHER

Pancreatic Cancer Risk Model (PRISM)

A neural network model (PrismNN) and a logistic regression model (PrismLR) that use routinely collected EHR data to stratify individuals from the general population into PDAC risk groups

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

collaborator

TriNetX, LLC

UNKNOWN

lead

Beth Israel Deaconess Medical Center

OTHER